The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy - Koster, J C; Cadario, F; Peruzzi, C (J Clin Endocrinol Metab, 2008)
EK III